Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

See our updated masking policy »

Stanford Health Care

Clinical and dosimetric considerations for Y90: recommendations from an international multidisciplinary working group. European journal of nuclear medicine and molecular imaging Salem, R., Padia, S. A., Lam, M., Bell, J., Chiesa, C., Fowers, K., Hamilton, B., Herman, J., Kappadath, S. C., Leung, T., Portelance, L., Sze, D., Garin, E. 2019

Abstract

The TheraSphere Global Dosimetry Steering Committee was formed in 2017 by BTG International to review existing data and address gaps in knowledge related to dosimetry. This committee is comprised of health care providers with diverse areas of expertise and perspectives on radiation dosimetry. The goal of these recommendations is to optimize glass microspheres radiation therapy for hepatocellular carcinoma while accounting for variables including disease presentation, tumour vascularity, liver function, and curative/palliative intent. The recommendations aim to unify glass microsphere users behind standardized dosimetry methodology that is simple, reproducible and supported by clinical data, with the overarching goal of improving clinical outcomes and advancing the knowledge of dosimetry.

View details for DOI 10.1007/s00259-019-04340-5

View details for PubMedID 31098749